Feeds:
Posts
Comments

Archive for the ‘Distressed IP’ Category

San Francisco, January, 2013
Gerbsman Partners – Maximizing Enterprise Value – partial industry and client summary
Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. Since 2001, Gerbsman Partners has been involved in maximizing value for 75 technology, life science and medical device companies and their Intellectual Property and has restructured/terminated over $810 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A Transactions.

Gerbsman Partners has offices and strategic alliances in San Francisco, New York, McLean, VA/DC, Orange County, Boston, Europe and Israel.

Technology – IP

Software

Emergent Game Technologies Inc – Licensed and supported 3D/game software.

Capital Thinking – Enterprise Risk Management (ERM) platform, a credit and risk management software solution for the financial services industry.

Cesura – Web and on demand business software.

Conformia Software Inc. – Software solutions for highly regulated process industries – Life Science.

deNovis – Enterprise software for government health and health insurance industry.

Aperion Inc. – Software.

Gentiae Inc. – Real-time fully automated processing of cardiac safety input and core lab operations. The system offers a comprehensive, real time web portal for sponsor and site access.

Banquet – Interactive sports entertainment.

ID Engines Inc. – Role-based access control (RBAC) across enterprise networks.

InDplay Inc. – Online, B2B video content distribution (monetization) platform, deployed on enterprise-quality software components, served in the SaaS (software-as-a-service) model.

Metreo Inc. – Pricing software for manufacturers and distributors.

Neohapsis Inc. – IT management services platform.

Zone4Play – Interactive game technology.

Roots Web, Inc. – Geneology software.

StreamSearch, Inc. – Multimedia aggregator that has created a unique solution for indexing, locating, promoting, and distributing rich media on the Internet.

Technion University – Technology patents

Teranode Corporation – Business intelligence and lab automation solutions for the Life Science market.

USA Democracy, Inc. – Direct, verifiable, credible communications between elected representatives and their constituents through its non-partisan legislative-based website.

Utility.com, Inc. – Multi-utility eCommerce/eCRM technology, Web-based energy management technology.

Vcommerce, Inc. – Developed, deployed, and operated fully integrated, end-to-end supply chain execution systems and direct fulfillment infrastructure.

Intelectron, Inc. – Commercial lighting technology.

Skunk Technologies – Java based technology.

Telecom

Dialpad, Inc. – Web-to-phone service.

Simpler Networks, Inc./Hercules Technology Growth Capital – Telco software – a matrix switch platform that sits within the Telco’s central office (CO) or street cabinets. Developed to allow for universal access to any service, the system’s protocol-transparent design allows it to be placed in front of any existing or future access gear that delivers services over the local loop
Storage

Cornice Inc. – Storage and flash controllers.

PhaseMetrics Inc. – Storage systems manufacturer.

Plasmon, Inc. – Data archival storage technology
Networking/Optical Networking

CipherMax, Inc. – Storage networking.

Private Networks, Inc. – Broadband multicast delivery system utilizing digital satellite technology. The technology has universal applicability to many industries for distribution of high-band data and video.

Teak Technologies Inc. – Internet switching and gateway networking products.

Zeus Communications, Inc. – Hardware architecture of 10 Gbps IPSec VPN and firewall in a single board.

Optivia, Inc & Hercules Technology Growth Capital – Optical transport systems.

Princeton Lightwave, Inc. – Optical networking technology

T-Networks, Inc. – Optical networking components.

Transparent Networks, Inc. – Wavelength Selective Switch, a high performance large scale Photonic cross-connect functional prototype, detailed design and simulation validation of a Light Path Exchange with integrated DWDM, an HDTV display mirror array high level design and simulation, proprietary and unique MEMS design and validation engineering tools.

Network Photonics, Inc.

Cambridge NanoTech, Inc.- Materials Science company that developed high Performance turnkey equipment for Atomic Layer Deposition (“ALD”).
Mobile

eBiz mobility – Mobile business payment

YPS Software – ASP and software vendor for the PC and mobile phone industries, Mobile Entertainment Centre.

Teleflip – Mobile messaging.
Media/Advertising/Internet

Active Response Group Inc. – On line marketing company.

Akimbo Inc. – Monitizing on line media.

Competition Accessories, Inc. – Online direct marketing.

Gallery Player Inc. – Provider and distributor of high-value, rights managed high definition imagery for high definition televisions.

MeMedia Inc. – Online advertising solutions provider and ad network that delivers contextually and behaviorally targeted advertisements across a multi-modal network of websites and desktop applications.

MyWire Inc. – Paid content and advertising.

NebuAd, Inc. – Online advertising model. Next-generation digital media technology and solutions.

Holographic & Biometric Technology

Aprilis, Inc./Dow Corning – Holographic Data Storage Drives and Biometric Secuirty Systems
Security

NeoScale Inc. – Storage encryption and key management solution for organizations securing information stored on tape and disk media.

Oviso Inc. – Semi conductor manufacturing equipment.

SciCortex, Inc. – Manufacturer of high performance computers.

Medical Device

Cardiovascular, Vascular, Endoscopy

Cardiomind inc. – Stent delivery platform.

OmniSonics Medical Technologies Inc. – Vascular disease IP.

InnerPulse Inc. – Cardiac rhythm management (CRM) medical device company.

Myocor Inc. – Developing innovative cardiac reshaping devices to treat functional mitral regurgitation (FMR) and left ventricular (LV) dysfunction, both of which are significant in the progression of congestive heart failure (CHF).

NDO Surgical, Inc. – Flexible endoscopy technologies that enable surgical procedures through the bodys natural openings.

Viacor Inc. – Cardiac implant device for the treatment of functional mitral regurgitation.

XTENT Inc. – Customizable drug eluting stent systems for the treatment of cardiovascular disease.

Spine

Applied Spine Technologies Inc – Screw based dynamic stabilization system validated with Class 1 clinical data

Emphasis Medical Inc. – Endobronchial valves for the treatment of heterogeneous emphysema.
Orthopeadics

NovaLign Orthopedic Inc. – Long bone fracture, intramedullary nail technology.
Opthomology

Optobionics – Retinal degeneration.

Refractec, Inc – Radiofrequency (RF) device called ViewPoint CK System, used to perform NearVisionSM CK (Conductive Keratoplasty) treatment
Obesity

Satiety Inc. – Obesity product

Life Science

Pluristem, Inc. – Stem cell research – Israel company

Barnev Inc. – Monitoring Systems, Labor Israel company.

Pegasus Biologics Inc. – Developed and is commercializing a revolutionary bioscaffold comprised of highly organized collagen, sourced from equine pericardium that encourages the healing process by addressing the demands of a challenging biological environment.

Radiant Medical, Inc. – Endovascular therapeutic cooling.

Valentis, Inc. – Biotechnology company with small molecule, antibody, protein, gene and manufacturing assets.
Solar

Nanosolar

AQT Solar

SVTC Solar

GERBSMAN PARTNERS
Email: steve@gerbsmanpartners.com
Web: http://www.gerbsmanpartners.com
BLOG of Intellectual Capital: blog.gerbsmanpartners.com
Skype: thegerbs

Read Full Post »

San Francisco, January, 2013
Successful “Date Certain M&A” of Materials Science company, its Assets and Intellectual Property
Steven R. Gerbsman, Principal of Gerbsman Partners (http://gerbsmanpartners.com)and James McHugh, a member of Gerbsman Partners Board of Intellectual Capital, announced today their success in maximizing stakeholder value for a materials science company. The company designed, developed and manufactured high performance turnkey equipment for Atomic Layer Deposition (“ALD”).

Gerbsman Partners provided Crisis Management and Investment Banking leadership, facilitated the sale of the business unit’s assets and its associated Intellectual Property. Due to market conditions, Board of Directors and the Senior Lender made the strategic decision to maximize the value of the business unit and Intellectual Property.

Gerbsman Partners provided leadership to the company with:

1.  Crisis Management and technology domain expertise in developing the strategic action plans for maximizing value of the business unit, Intellectual Property and assets;
2.  Proven domain expertise in maximizing the value of the business unit and Intellectual Property through a Gerbsman Partners targeted and proprietary “Date Certain M&A Process”;
3.  The ability to “Manage the Process” among potential Acquirers, Lawyers, Creditors Management and Advisors;
4.  The proven ability to “Drive” toward successful closure for all parties at interest.
About Gerbsman Partners

Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. Since 2001, Gerbsman Partners has been involved in maximizing value for 75 Technology, Life Science and Medical Device companies and their Intellectual Property and has restructured/terminated over $810 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A transactions.

Gerbsman Partners has offices and strategic alliances in Boston, New York, Washington, DC, San Francisco, Orange County, Europe and Israel. For additional information please visit http://www.gerbsmanpartners.com or Gerbsman Partners blog.

Read Full Post »

 

SOLID STATE TECHNOLOGY – Insights for Electronics Manufacturing

Ultratech buys Cambridge Nanotech assets, adds ALD tech

12/20/2012
By James Montgomery
News Editor

December 20, 2012 – Ultratech has acquired the assets of Cambridge Nanotech, a developer and supplier of atomic-layer deposition (ALD) technology with hundreds of installed systems in the field. Financial terms were not disclosed.

The company says adding the ALD technology will expand its nanotechnology and IP portfolio, enabling it to address new areas within the electronics industry and entry into new markets such as biomedical and energy. “By increasing our IP and expanding our nanotechnology portfolio to new levels, we expect to generate a new revenue stream in existing and new markets,” stated Ultratech chairman/CEO Art Zafiropoulo.

Cambridge Nanotech was founded in 2003 by Jill Becker based on her Ph.D work in ALD at Harvard University. Weeks ago Cambridge Nanotech was quietly put up on the auction block; an announcement by Gerbsman Partners, the firm retained by the firm’s main backer Silicon Valley Bank, noted that the company had ceased operations on November 9 and that an auction would take place on Dec. 14. The firm indicated Cambridge Nanotech’s sales from 2004-2011 increased at a 84% CAGR (to $18.7M in 2011, according to a local report), with initial profitability after the first year but “lumpy” since then. “Recent working capital constraints and an overly leveraged balance sheet” were cited as the reasons for the decision to sell the company’s assets.

The asset sale includes several ALD product and technology lines, in place at academic and manufacturing environments for a range of electronics, MEMS/MOEMS, display/lighting, and energy applications:

– “Savannah” — R&D lab equipment
– “Fiji” — R&D lab equipment with plasma and additional
– “Phoenix” and “Tahiti” — Production equipment for high-volume manufacturing
– “Preboost” — To proliferate the use of more precursors in any ALD system
– “Roll2Roll” — Fast ALD; high throughput; atmospheric ALD

Read Full Post »

Article from GigaOm.

Chinese auto tech behemoth Wanxiang has won the bidding process in an auction to buy the assets of bankrupt battery maker A123 Systems. On Sunday the companies announced that Wanxiang plans to acquire most of the assets of A123 for $256.6 million. It’s news that could be a bit controversial, given A123 received a $132 million grant from the U.S. government, and could now be owned by a Chinese company.

The winning bid beat out Johnson Control’s bid to acquire A123′s automotive division. Johnson Controls previously had offered to buy the automotive division and two factories for $125 million.

One of the reasons Wanxiang’s offer to buy up A123 had been controversial was because A123 had some U.S. military contracts, which critics didn’t want to see in the hands of a Chinese company. But A123 decided to sell off its government business, including all its U.S. military contracts, to Illinois-based company Navitas Systems, for $2.25 million. Wanxiang acquired the rest of the assets including the grid storage business.

We’ll see if that move silences politician critics like U.S. Sens. John Thune (R-S.D.) and Charles E. Grassley (R-Iowa). The deal still has to be approved by the bankruptcy court as well as the Committee for Foreign Investment in the United States (CIFIUS).

If approved, the future of A123 System’s lithium ion battery tech will fittingly be owned by a Chinese auto giant, as China is increasingly becoming one of the most important markets for electric vehicles. Money from Chinese investors, conglomerates, cities and the government, continues to drive a significant amount of the future of next-generation electric car technology.

The deal also provides a future for A123′s technology, which had a promising beginning, but had suffered a series of setbacks in 2012. Venture-backed A123 held the largest IPO in 2009, raising some $371 million, and was trading at over $20 per share when it started trading. A123 also raised more than $350 million from private investors when it was still a startup.

Yet in recent months, it suffered from manufacturing problems, and also had only a handful of customers for its premium batteries. The company had been losing boat loads of money for years.

The Wanxiang deal still won’t make back enough to cover its debts. A123 says:

Because the total purchase price for A123’s assets would be less than the total amount owed to creditors, the Company does not anticipate any recoveries for its current shareholders and believes its stock to have no value.

Now that the A123 bankruptcy is moving forward, it will be interesting to see what Fisker Automotive, one of A123′s prime customers, will do. Fisker had told the media that it is waiting for the results of the A123 auction before it starts back up assembling its Karma cars.

This isn’t Wanxiang’s first cleantech and clean energy acquisition — it’s actually its fifth in 2012, says the company in a release. Wanxiang has been aggressively acquiring under valued American cleantech and clean energy companies.

Read more here.

Read Full Post »

Bidding Process – Procedures for the Sale of certain Assets and Intellectual Property of Cambridge NanoTech, Inc.

Further to Gerbsman Partners e-mail of November 19, 2012 and November 26, 2012 regarding the sale of certain assets of Cambridge NanoTech, Inc., Inc., I attach the draft legal documents (Purchase and Sale Agreement and Secured Party’s Bill of Sale) that we will be requesting of bidders for certain Assets and Intellectual Property of Cambridge NanoTech, Inc.  All parties bidding on the assets are encouraged, to the greatest extent possible, to conform the terms of their bids to the terms and form of the attached agreement.  Any and all of the assets of Cambridge NanoTech, Inc. will be sold on an “as is, where is” basis and will be subject to “The Bidding Process for Interested Buyers”, outlined below.

Please be advised that the Cambridge NanoTech Assets are being offered for sale pursuant to Section 9-610 of the Uniform Commercial Code.  Purchasers of the Cambridge NanoTech Assets will receive all of Cambridge NanoTech’s right, title, and interest in the purchased portion of  SVB’s collateral, which consists of substantially all of Cambridge NanoTech’s assets, as provided in the Uniform Commercial Code.

I would also encourage all interested parties to have their counsel speak with Donald Rothman, Esq. and/or Alexander Rheaume, Esq., counsel to Silicon Valley Bank to review the Purchase & Sale Agreement prior to submitting their Bid and date of December 12, 2012.

For additional information please contact Donald Rothman, Esq, 617 880 3556 and/or Alexander Rheaume, Esq. 617 8808 3492.  drothman@riemerlaw.com – arheaume@riemerlaw.com

Please review in detail, the “Bidding Process for Interested Buyers” below.

Updates include:

1.  All bids must indicate a separate bid amount for accounts receivable if interested in bidding on the A/R;

2.  All bids submitted shall be binding and shall remain open until the consummation of the sale(s) to one or more Successful Bidders.  SVB may sell the Cambridge NanoTech Assets to the second highest bidder at the Auction should a Successful Bidder fail to fulfill such Successful Bidder’s obligations under the applicable purchase and sale agreement.  No such sale of the Cambridge NanoTech Assets by SVB to such second highest bidder shall relieve a Successful Bidder from its obligations under the purchase and sale agreement nor operate as a waiver by SVB of its rights and remedies against a Successful Bidder.
 
The key dates and terms include:

The Bidding Process for Interested Buyers

Due Diligence:

Interested and qualified parties will be required to sign a nondisclosure agreement in the form attached hereto as Exhibit A to have access to the due diligence “war room” documentation (the “Due Diligence Access”). Each interested party, as a consequence of the Due Diligence Access granted to it, shall be deemed to acknowledge and represent (i) that it is bound by the bidding procedures described herein; (ii) that it has an opportunity to inspect and examine the Cambridge NanoTech Assets and to review all pertinent documents and information with respect thereto; (iii) that it is not relying upon any written or oral statements, representations, or warranties of SVB or Gerbsman Partners, or their respective staff, agents, or attorneys; and (iv) all such documents and reports have been provided solely for the convenience of the interested party, and SVB or Gerbsman Partners (and their respective, staff, agents, or attorneys) do not make any representations as to the accuracy or completeness of the same.

Qualifying to Bid at Auction:

The Cambridge NanoTech Assets will be sold pursuant to a secured party’s public auction sale.  In order to qualify to bid at the public auction sale, interested parties must submit initial bids for the Cambridge NanoTech Assets so that they areactually received by Gerbsman Partners via email to steve@gerbsmanpartners.com no later than Thursday, December 12, 2012 at 3:00 p.m. Eastern Standard Time (the “Initial Bid Deadline”) with a copy to Riemer and Braunstein LLP, 3 Center Plaza, Boston, MA, 02108. Attention: Donald E. Rothman, Esq. and via email to drothman@riemerlaw.com.

Any person or other entity making a bid must be prepared to provide independent confirmation that they possess the financial resources to complete the purchase where applicable.  In order to qualify to bid at the public auction sale, all initial bids must be accompanied by a refundable deposit in the amount of $200,000 which shall be paid to Riemer & Braunstein LLP as escrow agent (the “Escrow Agent”) in accordance with the wire instructions attached hereto as Exhibit “B”. All deposits shall be held in a non-interest bearing account.  Non-successful bidders will have their deposit returned to them within five (5) business days following the completion of the public auction sale. The deposit of the Successful Bidder (as defined below) shall be held by the Escrow Agent pending the consummation of the sale in accordance with the terms and conditions of the sales agreement to be executed by SVB and the Successful Bidder.

Initial bids should identify those assets being tendered for and in a specific and identifiable way. The attached Cambridge NanoTech fixed asset list (Exhibit “C”) may not be complete. All bids must indicate a separate bid amount for accounts receivable if interested in bidding on the A/R.

All bids submitted shall be binding and shall remain open until the consummation of the sale(s) to one or more Successful Bidders.  SVB may sell the Cambridge NanoTech Assets to the second highest bidder at the Auction should a Successful Bidder fail to fulfill such Successful Bidder’s obligations under the applicable purchase and sale agreement.  No such sale of the Cambridge NanoTech Assets by SVB to such second highest bidder shall relieve a Successful Bidder from its obligations under the purchase and sale agreement nor operate as a waiver by SVB of its rights and remedies against a Successful Bidder.

SVB shall be deemed to be a qualified bidder.
 
Public Auction Sale:

On Friday December 14, 2012, a public auction sale (the “Auction”) of the Cambridge NanoTech Assets will be conducted among all qualified bidders commencing at 11:00am Eastern Standard Time at the offices of Riemer & Braunstein LLP, 3 Center Plaza, Boston, MA, 02108.  Qualified bidders shall appear in person at the Auction or participate by telephone conference.  The dial in numbers are Domestic – 888 640-4172, International 913 227-1228, participation code 617 880 3556

SVB reserves the right to cancel, postpone, or adjourn the Auction to such other time or times as the Secured Party may deem proper by announcement made at the Auction, and any subsequent adjournment thereof, either before or after the commencement of bidding, without written notice or further publication.  The Auction may be resumed without further notice or publication at the time and place at which such Auction may have been adjourned.

Prior to the start of the Auction, the auctioneer will advise all qualified bidders of what SVB believes to be the highest or otherwise best qualified bid(s) with respect to the sale (each a “Stalking Horse Bid”).  Only qualified bidders are eligible to participate in the Auction.  Bidding at the Auction shall begin initially with the Stalking Horse Bid(s) and shall subsequently continue in such minimum increments as the auctioneer determines.

Bidding will continue with respect to the Auction until SVB determines that it has received the highest or otherwise best bid(s) for the Cambridge NanoTech Assets.  After SVB so determines, the auctioneer will close the Auction, subject, however, to SVB’s right to re-open the Auction if necessary.  SVB will then determine and announce which bid(s) has/have been determined to be the highest or otherwise best bid(s) (each a “Successful Bid”) and the holder of each Successful Bid shall be deemed to be a “Successful Bidder”.

SVB reserves the right to (i) determine in its reasonable discretion which bid is the highest or best bid and (ii) reject at any time prior to the execution of a purchase agreement, any offer that SVB in its reasonable discretion deems to be (x) inadequate or insufficient, or (y) contrary to the best interests of SVB.  In determining which bid(s) is/are a Successful Bid, economic considerations shall not be the sole criterion upon which SVB may base its decision and SVB shall take into account all factors it reasonably believes to be relevant in an exercise of its business judgment.

Each Successful Bidder will then be required to immediately execute and deliver a purchase agreement to SVB in the form attached hereto as Exhibit “D”. SVB will require each Successful Bidder at the Auction to close within 7 days after the Auction. Any or all of the assets of Cambridge NanoTech will be sold on an “as is, where is” basis, with no representation or warranties whatsoever.

SVB reserves the right at any time to (i) extend the deadlines set forth herein and/or adjourn the Auction without further notice, (ii) offer any portion of the Cambridge NanoTech Assets to be sold separately at the Auction if SVB determines to do so, (iii) withdraw any of the Cambridge NanoTech Assets at any time prior to or during the Auction, to make subsequent attempts to market the same, (iv) reject any or all bids if, in SVB’s reasonable business judgment, no bid is for a fair and adequate price, and (v) otherwise modify the sale procedures in its reasonable discretion.

All sales, transfer, and recording taxes, stamp taxes, or similar taxes, if any, relating to the sale of the Cambridge NanoTech Assets shall be the sole responsibility of the applicable Successful Bidder.

For additional information, please see below and/or contact:

Steven R. Gerbsman
Gerbsman Partners
(415) 456-0628
steve@gerbsmanpartners.com

James McHugh
Gerbsman Partners
(978) 239-7296
Jim@mchughco.com

Donald Rothman, Esq.
Riemer Braunstein LLP
(617) 880-3556
drothman@riemerlaw.com

Read Full Post »

« Newer Posts - Older Posts »